NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report a patient with GNE myopathy with a homozygous mutation (c.1505-4G>A) in GNE gene.
|
27919547 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
GNE mutations causing distal myopathy with rimmed vacuoles with inflammation.
|
12913203 |
2003 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary inclusion-body myopathy or distal myopathy with rimmed vacuoles (h-IBM/DMRV) is due to mutations of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene, which codes for an enzyme of the sialic acid biosynthetic pathway.
|
20644153 |
2010 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
GNE myopathy (MIM 600737) is an autosomal recessive muscle disease caused by mutations in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene.
|
22231866 |
2012 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Most of the current information on GNE myopathy has been obtained through studies of Jewish and Japanese patient cohorts carrying founder mutations in the GNE gene.
|
24695763 |
2014 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our findings expand the genetic spectrum of DMRV and indicate that the common mutations of GNE gene in DMRV may be variable among different ethnic populations.
|
21307865 |
2011 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our study demonstrates the mutation spectrum of the GNE gene in Thai patients with DMRV.
|
16810679 |
2006 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive hereditary inclusion-body myopathy (h-IBM) is caused by mutations of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene, a rate-limiting enzyme in the sialic acid metabolic pathway.
|
18182043 |
2008 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation of methionine 743 in the GNE leads to a 30% reduction of the enzyme activity and is responsible for an aggressive form of GNE myopathy.
|
27037841 |
2016 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary inclusion body myopathy (HIBM) is a genetic muscle disease due to mutations in the gene encoding the enzyme complex UDP-N-acetylglucosamine 2 epimerase-N-acetylmannosamine kinase (GNE), which catalyzes the rate-limiting step in sialic acid production.
|
19019317 |
2008 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy.
|
15147877 |
2004 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This study aimed to investigate the variability of clinical and morphological presentation and the spectrum of Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) mutations in Chinese DMRV patients.
|
22196754 |
2011 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the GNE gene associated with IBM2 in affected individuals from four IBMPFD families did not identify any mutations, indicating that the two disorders are not allelic.
|
12921793 |
2003 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation update for GNE gene variants associated with GNE myopathy.
|
24796702 |
2014 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This is the first deletion event observed in a GNE allele and expands the molecular pathogenesis of autosomal-recessive h-IBM.
|
12811782 |
2003 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase gene cause GNE myopathy, a mildly progressive autosomal recessive myopathy.
|
24656604 |
2014 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A single patient (patient 001) with severe HIBM treated with a compassionate investigational new drug received seven doses of GNE gene lipoplex via intravenous infusion at the following doses: 0.4, 0.4, 1.0, 4.0, 5.0, 6.0, and 7.0 mg of DNA.
|
21517694 |
2011 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
UDP N-acetylglucosamine2-epimerase/N-acetylmannosamine-kinase (GNE) gene mutations can cause mostly autosomal-recessive myopathy with juvenile-onset known as hereditary inclusion-body myopathy (HIBM).
|
30990900 |
2019 |
NONAKA MYOPATHY
|
0.800 |
Biomarker
|
disease |
BEFREE |
Our study clearly demonstrates that Dd can be used as an expression host for the production of recombinant and functionally active form of GNE and its mutant proteins that can be used for biophysical characterization and structural determination of GNE to understand the pathomechanism of HIBM.
|
25230235 |
2014 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
GNE myopathy is a rare autosomal recessive inheritance disease due to the mutation of GNE gene.
|
28284578 |
2017 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
To elucidate the pathological mechanisms leading from the mutated GNE to the HIBM phenotype, we attempted to identify and characterize early occurring downstream events by analyzing the genomic expression patterns of muscle specimens from 10 HIBM patients carrying the M712T Persian Jewish founder mutation and presenting mild histological changes, compared with 10 healthy matched control individuals, using GeneChip expression microarrays.
|
18723858 |
2008 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
|
17704511 |
2007 |
NONAKA MYOPATHY
|
0.800 |
Biomarker
|
disease |
BEFREE |
We developed individual GNE and MNK enzymatic assays and determined reduced activities in cultured fibroblasts of patients, with HIBM harboring missense mutations in either or both the GNE and MNK enzymatic domains.
|
15987957 |
2005 |
NONAKA MYOPATHY
|
0.800 |
Biomarker
|
disease |
BEFREE |
The generation of HIBM animal models has led to novel insights into both the disease and the role of GNE/MNK in pathophysiology.
|
19596068 |
2009 |
NONAKA MYOPATHY
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The linkage scan excluded the majority of known myopathy genes, but one linkage peak included the gene GNE, in which mutations cause autosomal recessive hereditary inclusion body myopathy type 2 (HIBM2).
|
21708040 |
2011 |